Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Utility of Remdesivir in COVID-19 Patients with Acute Kidney Injury or Chronic Kidney Disease
IRCT20210709051824N1Phase 3Completed
- Sponsor
- Men's Health and Reproductive Health Research Center
- Start
- Dec 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of remdesivir in coronavirus disease 2019 (COVID-19), acute kidney failure (AKF) and chronic kidney disease (CKD), sponsored by Men's Health and Reproductive Health Research Center. Started Dec 2021; status: completed.
02
Drugs
remdesivir
03
Conditions
coronavirus disease 2019 (COVID-19)acute kidney failure (AKF)chronic kidney disease (CKD)
Beyond the preview
Go deeper on IRCT20210709051824N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210709051824N1.